McDonnell, D.; Afolabi, P.R.; Wilding, S.; Griffiths, G.O.; Swann, J.R.; Byrne, C.D.; Hamady, Z.Z.
Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma. Cancers 2023, 15, 5756.
https://doi.org/10.3390/cancers15245756
AMA Style
McDonnell D, Afolabi PR, Wilding S, Griffiths GO, Swann JR, Byrne CD, Hamady ZZ.
Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma. Cancers. 2023; 15(24):5756.
https://doi.org/10.3390/cancers15245756
Chicago/Turabian Style
McDonnell, Declan, Paul R. Afolabi, Sam Wilding, Gareth O. Griffiths, Jonathan R. Swann, Christopher D. Byrne, and Zaed Z. Hamady.
2023. "Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma" Cancers 15, no. 24: 5756.
https://doi.org/10.3390/cancers15245756
APA Style
McDonnell, D., Afolabi, P. R., Wilding, S., Griffiths, G. O., Swann, J. R., Byrne, C. D., & Hamady, Z. Z.
(2023). Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma. Cancers, 15(24), 5756.
https://doi.org/10.3390/cancers15245756